NYSE:APUS | Insider Transactions | Apimeds Pharmaceuticals US, Inc.

APUS Insider Transactions

4 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–4; provenance stays internal.

APUS insiders transaction timeline

PurchaseSale
2025-05-12: 2 purchases — Koo Jakap, Inscobee Inc.2025-05-13: 1 purchase — Kim Christopher2025-05-14: 1 purchase — Kim Christopher2025-05-122025-05-14
Insider profileRoleDateTransactionSharesPrice
Kim ChristopherChairman and CMO2025-05-14Purchase7,730.0$1.86
Kim ChristopherChairman and CMO2025-05-13Purchase19,770.0$1.82
Koo JakapDirector2025-05-12Purchase28,500.0$1.99
Inscobee Inc.TenPercentOwner2025-05-12Purchase500,000.0$4.0